血管塞栓術の世界市場レポート 2025年

血管塞栓術市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.6％で49億1,000万米ドルに成長します。予測期間の成長は、慢性疾患患者の増加、研究開発活動への投資の増加、低侵襲処置への嗜好の高まり、地理的拡大とヘルスケアへのアクセス、可処分所得の増加などに起因します。予測期間の主な動向としては、技術進歩、戦略的提携、戦略的提携、革新的な血管塞栓術機器の開発などが挙げられます。

血管疾患の有病率の増加が予想され、血管塞栓術市場の成長を牽引します。血管疾患には、動脈や静脈などの血管に影響を及ぼすさまざまな障害が含まれ、血流の低下や、末梢血管疾患、腹部大動脈瘤、深部静脈血栓症、アテローム性動脈硬化症、慢性静脈不全、末梢動脈疾患などのさまざまな状態につながります。血管塞栓術は、これらの疾患の治療薬として、血管の閉塞や閉塞を伴う出血への対処、動脈瘤の修復、静脈への血液供給の促進を行います。2023年4月現在、HMP Communications LLCは、2020年の末梢動脈疾患（PAD）の世界的有病率は2,100万件で、2030年には2,380万件に達すると予測しています。このことは、血管疾患の有病率の増加が血管塞栓術市場の主要な促進要因であることを示しています。

慢性腎臓病の高い有病率は、血管塞栓術市場の今後の成長を牽引すると予想されます。慢性腎臓病（CKD）は、時間の経過とともに腎臓に徐々に不可逆的な損傷が生じることを特徴とする疾患です。血管塞栓術はCKDにおいて、腎腫瘍、動静脈奇形（AVM）、腎生検や移植から生じる合併症からの出血をコントロールするために使用され、特に腎機能が低下した患者にとって、開腹手術に伴うリスクを回避することができます。例えば、英国の腎臓研究委員会であるZSアソシエイツの報告によると、英国における腎臓病の有病率は、2023年には人口の10％を超える719万人が罹患すると推定され、2033年には761万人に増加し、後期段階にある患者の割合は45％から51％に増加すると予測されています。このように、慢性腎臓病の有病率の上昇が血管塞栓術市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界血管塞栓術 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の血管塞栓術市場：成長率分析
• 世界の血管塞栓術市場の実績：規模と成長, 2019-2024
• 世界の血管塞栓術市場の予測：規模と成長, 2024-2029, 2034F
• 世界血管塞栓術総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血管塞栓術市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 塞栓剤
• 塞栓デバイス
• 世界の血管塞栓術市場塞栓術による、実績と予測, 2019-2024, 2024-2029F, 2034F
• コイル装置
• 非コイルデバイス
• 世界の血管塞栓術市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 末梢血管疾患
• 腫瘍学
• 泌尿器科
• 神経学
• その他の用途
• 世界の血管塞栓術市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 外来手術センター
• 診断センター
• 世界の血管塞栓術市場塞栓剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粒子塞栓剤
• 液体塞栓剤
• コイル塞栓剤
• ゼラチンスポンジ塞栓剤
• 世界の血管塞栓術市場、塞栓デバイスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• バルーン閉塞装置
• カテーテル
• トロンビン注入システム

第7章 地域別・国別分析

• 世界の血管塞栓術市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の血管塞栓術市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血管塞栓術市場：競合情勢
• 血管塞栓術市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• B. Braun Melsungen AG
• Kaneka Corporation
• Terumo Corporation
• W. L. Gore & Associates Inc.
• Teleflex Inc.
• Cook Group Incorporated
• Merit Medical Systems Inc.
• Penumbra Inc.
• MicroPort Scientific Corporation
• MicroVention Inc.
• Medikit Co Ltd.
• Silk Road Medical Inc.
• Galt Medical Corporation
• Neuravi Ltd.
• Phenox GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血管塞栓術市場2029：新たな機会を提供する国
• 血管塞栓術市場2029：新たな機会を提供するセグメント
• 血管塞栓術市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Vascular embolization is a minimally invasive procedure that utilizes different materials, including coils, particles, or liquid agents, to block or impede blood vessels, thereby halting arterial bleeding. This technique is employed for various purposes, such as treating malignancies, shrinking vascular abnormalities, or redirecting blood flow.

The main products associated with vascular embolization are embolic agents and embolization devices. Embolic agents are chemicals or materials injected or placed in specific regions to block or occlude blood vessels, effectively treating various medical conditions. These agents are utilized in different procedures to address medical issues such as tumors, aneurysms, and arteriovenous malformations (AVMs). Various embolization techniques include coiling devices and non-coiling devices, applied in diverse medical applications such as peripheral vascular diseases, oncology, urology, neurology, and others. These products cater to various end-users, including hospitals, specialty clinics, ambulatory surgical centers, and diagnostic centers.

The vascular embolization market research report is one of a series of new reports from The Business Research Company that provides vascular embolization market statistics, including vascular embolization industry global market size, regional shares, competitors with a vascular embolization market share, detailed vascular embolization market segments, market trends and opportunities, and any further data you may need to thrive in the vascular embolization industry. This vascular embolization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular embolization market size has grown strongly in recent years. It will grow from $3.15 billion in 2024 to $3.4 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rising prevalence of vascular diseases, rise in demand for non-coiling devices, surge in the use of clot agents, increased awareness about advanced treatment options

The vascular embolization market size is expected to see strong growth in the next few years. It will grow to $4.91 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growth in the cases of chronic diseases, rising investments in r&d activities, growing preference for minimally invasive procedures, geographic expansion and access to healthcare, rising disposable incomes. Major trends in the forecast period include technological advancements, strategic collaborations, strategic collaborations, development of innovative vascular embolization devices.

The anticipated rise in the prevalence of vascular diseases is set to drive the growth of the vascular embolization market. Vascular diseases encompass various disorders affecting blood vessels, including arteries and veins, leading to reduced blood flow and various conditions such as peripheral vascular disease, abdominal aortic aneurysm, deep vein thrombosis, atherosclerosis, chronic venous insufficiency, and peripheral artery diseases. Vascular embolization serves as a treatment for these disorders, involving the occlusion or obstruction of blood vessels to address bleeding, repair aneurysms, and enhance blood supply in veins. As of April 2023, HMP Communications LLC reported a global prevalence of 21 million cases of peripheral artery diseases (PAD) in 2020, projected to reach 23.8 million by 2030. This underlines how the increasing prevalence of vascular diseases is a key driver for the vascular embolization market.

The high prevalence of chronic kidney diseases is expected to drive the growth of the vascular embolization market in the future. Chronic Kidney Disease (CKD) is a condition characterized by the gradual and irreversible damage to the kidneys over time. Vascular embolization can be employed in CKD to control bleeding from kidney tumors, arteriovenous malformations (AVMs), or complications arising from kidney biopsies or transplants, thereby avoiding the risks associated with open surgery, particularly for patients with compromised kidney function. For example, a report by ZS Associates, a UK-based Kidney Research Commission, indicated that the prevalence of kidney disease in the UK was estimated to affect 7.19 million people in 2023, over 10% of the population, and is projected to rise to 7.61 million by 2033, with the percentage of patients in later stages of the disease increasing from 45% to 51%. Thus, the rising prevalence of chronic kidney diseases is propelling the growth of the vascular embolization market.

A prominent trend in the vascular embolization market is the adoption of technological advancements by major companies. These innovations are geared towards sustaining their market positions and enhancing the effectiveness of vascular embolization procedures. For example, in June 2022, India Medtronic Private Limited, a subsidiary of Medtronic plc, introduced the Pipeline Vantage, a flex embolization device designed for the treatment of brain aneurysms. This device incorporates shield technology and features improved delivery design characteristics, making it more reliable for clinicians to transport, deploy, and treat brain aneurysms.

Major companies in the vascular embolization market are focusing on developing innovative products such as embolic systems to drive profitability. Embolic systems, comprising embolic agents and delivery devices, are utilized to intentionally block blood vessels in medical procedures. In October 2023, Sirtex Medical launched the Lava liquid embolic system (LES), offering a versatile solution for controlled target vessel occlusion in peripheral vasculature. Its varied viscosity options enable effective distal embolization of small and hard-to-reach vessels, providing physicians with enhanced treatment options.

In August 2022, Boston Scientific Corporation acquired Obsidio. This acquisition aims to expand Boston Scientific Corporation's interventional oncology and embolization portfolio, offering unique options for physicians and patients dealing with hemorrhages, cancer, and other debilitating conditions. Obsidio specializes in minimally invasive blood vessel occlusion.

Major companies operating in the vascular embolization market include Abbott Laboratories, Medtronic Plc., Merck Group, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Kaneka Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Teleflex Inc., Cook Group Incorporated, Merit Medical Systems Inc., Penumbra Inc., MicroPort Scientific Corporation, MicroVention Inc., Medikit Co Ltd., Silk Road Medical Inc., Galt Medical Corporation, Neuravi Ltd., Phenox GmbH, Spartan Micro Inc., EndoShape Inc., Shape Memory Medical Inc., Balt Group, Vascular Solutions Inc.

North America was the largest region in the vascular embolization market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular embolization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the vascular embolization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The vascular embolization market consists of revenues earned by entities by providing vascular embolization techniques such as chemoembolization or radioembolization, sac packing, sandwich technique, stent-assisted coiling, and particle embolization. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular embolization market also includes sales of balloons, gelatin foam, liquid glue, liquid sclerosing agents, particulate agents, detachable coils, and push able coils. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vascular Embolization Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vascular embolization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vascular embolization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vascular embolization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Embolic Agents; Embolization Devices
• 2) By Embolization Technique: Coiling Devices; Non-Coiling Devices
• 3) By Application: Peripheral Vascular Diseases; Oncology; Urology; Neurology; Other Applications
• 4) By End Users: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Diagnostic Centers
• Subsegments:
• 1) By Embolic Agents: Particle Embolic Agents; Liquid Embolic Agents; Coil Embolic Agents; Gelatin Sponge Embolic Agents
• 2) By Embolization Devices: Balloon Occlusion Devices; Catheters; Thrombin Injection Systems
• Companies Mentioned: Abbott Laboratories; Medtronic Plc.; Merck Group; Stryker Corporation; Boston Scientific Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vascular Embolization Market Characteristics

3. Vascular Embolization Market Trends And Strategies

4. Vascular Embolization Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Vascular Embolization Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vascular Embolization PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vascular Embolization Market Growth Rate Analysis
• 5.4. Global Vascular Embolization Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vascular Embolization Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vascular Embolization Total Addressable Market (TAM)

6. Vascular Embolization Market Segmentation

• 6.1. Global Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Embolic Agents
• Embolization Devices
• 6.2. Global Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coiling Devices
• Non-Coiling Devices
• 6.3. Global Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peripheral Vascular Diseases
• Oncology
• Urology
• Neurology
• Other Applications
• 6.4. Global Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers
• 6.5. Global Vascular Embolization Market, Sub-Segmentation Of Embolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Particle Embolic Agents
• Liquid Embolic Agents
• Coil Embolic Agents
• Gelatin Sponge Embolic Agents
• 6.6. Global Vascular Embolization Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Balloon Occlusion Devices
• Catheters
• Thrombin Injection Systems

7. Vascular Embolization Market Regional And Country Analysis

• 7.1. Global Vascular Embolization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vascular Embolization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vascular Embolization Market

• 8.1. Asia-Pacific Vascular Embolization Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vascular Embolization Market

• 9.1. China Vascular Embolization Market Overview
• 9.2. China Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vascular Embolization Market

• 10.1. India Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vascular Embolization Market

• 11.1. Japan Vascular Embolization Market Overview
• 11.2. Japan Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vascular Embolization Market

• 12.1. Australia Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vascular Embolization Market

• 13.1. Indonesia Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vascular Embolization Market

• 14.1. South Korea Vascular Embolization Market Overview
• 14.2. South Korea Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vascular Embolization Market

• 15.1. Western Europe Vascular Embolization Market Overview
• 15.2. Western Europe Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vascular Embolization Market

• 16.1. UK Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vascular Embolization Market

• 17.1. Germany Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vascular Embolization Market

• 18.1. France Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vascular Embolization Market

• 19.1. Italy Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vascular Embolization Market

• 20.1. Spain Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vascular Embolization Market

• 21.1. Eastern Europe Vascular Embolization Market Overview
• 21.2. Eastern Europe Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vascular Embolization Market

• 22.1. Russia Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vascular Embolization Market

• 23.1. North America Vascular Embolization Market Overview
• 23.2. North America Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vascular Embolization Market

• 24.1. USA Vascular Embolization Market Overview
• 24.2. USA Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vascular Embolization Market

• 25.1. Canada Vascular Embolization Market Overview
• 25.2. Canada Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vascular Embolization Market

• 26.1. South America Vascular Embolization Market Overview
• 26.2. South America Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vascular Embolization Market

• 27.1. Brazil Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vascular Embolization Market

• 28.1. Middle East Vascular Embolization Market Overview
• 28.2. Middle East Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vascular Embolization Market

• 29.1. Africa Vascular Embolization Market Overview
• 29.2. Africa Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vascular Embolization Market Competitive Landscape And Company Profiles

• 30.1. Vascular Embolization Market Competitive Landscape
• 30.2. Vascular Embolization Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Vascular Embolization Market Other Major And Innovative Companies

• 31.1. B. Braun Melsungen AG
• 31.2. Kaneka Corporation
• 31.3. Terumo Corporation
• 31.4. W. L. Gore & Associates Inc.
• 31.5. Teleflex Inc.
• 31.6. Cook Group Incorporated
• 31.7. Merit Medical Systems Inc.
• 31.8. Penumbra Inc.
• 31.9. MicroPort Scientific Corporation
• 31.10. MicroVention Inc.
• 31.11. Medikit Co Ltd.
• 31.12. Silk Road Medical Inc.
• 31.13. Galt Medical Corporation
• 31.14. Neuravi Ltd.
• 31.15. Phenox GmbH

32. Global Vascular Embolization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vascular Embolization Market

34. Recent Developments In The Vascular Embolization Market

35. Vascular Embolization Market High Potential Countries, Segments and Strategies

• 35.1 Vascular Embolization Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vascular Embolization Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vascular Embolization Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer